Xenon Pharmaceuticals Inc. Gains 101.92%
Mon, Oct 04, 2021 at 05:30 PM
Xenon Pharmaceuticals Inc. (XENE:NASDAQ) soared at $31.5, a gain of 101.9%. The stock got featured on our News Catalysts scanner on Mon, Oct 04, 2021 at 03:23 PM in the 'MISCELLANEOUS' category. From Fri, Sep 17, 2021, the stock recorded 40.00% Up Days and 36.36% Green Days
The share price of the company has been moving sideways in recent weeks.
About Xenon Pharmaceuticals Inc. (XENE:NASDAQ)
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its products portfolio includes Glybera, TV-45070.
Top 10 Gainers:
- Xenon Pharmaceuticals Inc. (XENE:NASDAQ), 101.92%
- Elmira Savings Bank (ESBK:NASDAQ), 68.15%
- Mexco Energy Corporation (MXC:NYSEMKT), 46.42%
- LGHL (LGHL:NASDAQ), 26%
- Superior Drilling Products, Inc. (SDPI:NYSEMKT), 23.68%
- Ring Energy, Inc. (REI:NYSEMKT), 18.79%
- Verb Technology Company, Inc. (VERB:NASDAQ), 18.46%
- U.S. Well Services, Inc. (USWS:NASDAQ), 16.41%
- Enservco Corporation (ENSV:NYSEMKT), 14.97%
- New Concept Energy, Inc. (GBR:NYSEMKT), 14.38%